Core Laboratories Inc. (NYSE:CLB) Shares Acquired by Northern Trust Corp

Northern Trust Corp boosted its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 15.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 577,752 shares of the oil and gas company's stock after acquiring an additional 78,173 shares during the quarter. Northern Trust Corp owned 1.23% of Core Laboratories worth $10,001,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Assetmark Inc. acquired a new stake in Core Laboratories in the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC increased its position in Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after acquiring an additional 1,293 shares during the period. Nisa Investment Advisors LLC increased its position in Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after acquiring an additional 2,339 shares during the period. Tower Research Capital LLC TRC increased its position in Core Laboratories by 843.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock valued at $57,000 after acquiring an additional 2,936 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new stake in Core Laboratories in the 4th quarter valued at approximately $149,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Price Performance

Shares of CLB stock traded down $0.05 during mid-day trading on Friday, hitting $10.88. 434,650 shares of the stock traded hands, compared to its average volume of 405,172. Core Laboratories Inc. has a twelve month low of $10.14 and a twelve month high of $25.13. The firm has a market cap of $509.85 million, a price-to-earnings ratio of 16.48, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45. The company's 50-day simple moving average is $12.62 and its 200-day simple moving average is $16.20. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The firm had revenue of $123.59 million for the quarter, compared to analyst estimates of $125.09 million. During the same quarter last year, the business posted $0.19 earnings per share. The firm's revenue for the quarter was down 4.7% compared to the same quarter last year. As a group, equities research analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend is Monday, May 5th. Core Laboratories's dividend payout ratio (DPR) is presently 6.78%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CLB shares. Stifel Nicolaus lowered their target price on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research report on Tuesday, April 15th. Citigroup lowered their target price on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Finally, Wall Street Zen cut Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. Based on data from MarketBeat.com, Core Laboratories has an average rating of "Hold" and an average target price of $15.00.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.